Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran

被引:7
|
作者
Farzan Kianersi
Afsaneh Naderi Beni
Zahra Naderi Beni
机构
[1] Isfahan University of Medical Sciences,Isfahan Eye Research Center
[2] Shahrekord University of Medical Sciences and Health Services,Department of Ophthalmology
[3] Kashani Hospital,undefined
关键词
Ocular toxoplasmosis; Manifestation; Complication;
D O I
10.1007/s10792-012-9599-0
中图分类号
学科分类号
摘要
Toxoplasmosis is the most common cause of posterior uveitis in the world. This study described the clinical characteristics and visual outcome of 193 patients with ocular toxoplasmosis at Feiz Hospital (Isfahan, Iran) during the last six years. The setting and design used was a retrospective non-comparative observational case series. In this study, 193 patients with ocular toxoplasmosis (111 female, 82 male) were enrolled. The distribution of symptoms and fundoscopic findings were studied. The most-reported chief complaint was blurred vision in 96 % (184 patients) and floaters in 13.47 % (25 patients) of cases and most frequent clinical manifestations were chorioretinitis 98.48 % (190 patients), macular scars 50.7 % (98 patients), and atrophic optic papilla two (1.03 %) patients. Primary retinal lesions were observed in 16 (8.2 %) and combination of active lesions and old retinochoroidal scars in 177 (91.7 %) of the patients. Retinal detachment occurred in 11 (5.69 %) patients. Bilateral involvement was found in 27 % of patients. Blindness was 0.05 % after treatment. Recurrence rate was 14.5 %. In conclusion, ocular toxoplasmosis substantially varies among patients with different age, gender, site of lesion and other factors. Suddenly blurred vision, floater, and pain could be caused by Toxoplasma gondii. Flashing, may necessitate a more precise peripheral fundus examination.
引用
收藏
页码:539 / 545
页数:6
相关论文
共 50 条
  • [21] OCULAR TOXOPLASMOSIS - CLINICAL AND EXPERIMENTAL OBSERVATIONS
    HOGAN, MJ
    ARCHIVES OF OPHTHALMOLOGY, 1955, 53 (06) : 916 - 918
  • [22] T cell immunoregulation in active ocular toxoplasmosis
    Cordeiro, Cynthia A.
    Vieira, Erica L. M.
    Castro, Vinicius M.
    Dutra, Walderez O.
    Costa, Rogerio A.
    Orefice, Juliana L.
    Campos, Wesley R.
    Orefice, Fernando
    Young, Lucy H.
    Teixeira, Antonio Lucio
    IMMUNOLOGY LETTERS, 2017, 184 : 84 - 91
  • [23] Clinical and laboratory diagnosis of ocular toxoplasmosis
    Garweg, Justus G.
    Peyron, Francois
    EXPERT REVIEW OF OPHTHALMOLOGY, 2008, 3 (03) : 333 - 346
  • [24] The role of serology in active ocular toxoplasmosis.
    Papadia M.
    Aldigeri R.
    Herbort C.P.
    International Ophthalmology, 2011, 31 (6) : 461 - 465
  • [25] Clinical ocular toxoplasmosis in neonatal kittens
    Powell, CC
    Lappin, MR
    VETERINARY OPHTHALMOLOGY, 2001, 4 (02) : 87 - 92
  • [26] Clinical Features and Treatment of Ocular Toxoplasmosis
    Park, Young-Hoon
    Nam, Ho-Woo
    KOREAN JOURNAL OF PARASITOLOGY, 2013, 51 (04): : 393 - 399
  • [27] Comparison of Two Treatments in Active Ocular Toxoplasmosis
    Lucila Urdapilleta, Mariana
    Pedroza-Seres, Miguel
    Guinto Arcos, Ethel Beatriz
    Bobadilla, Rosalva
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [28] Bilateral ocular toxoplasmosis: a clinical case
    Di Marzio, G
    Capone, P
    Di Marzio, L
    Ricci, B
    Di Bonaventura, G
    Morbiducci, G
    Di Norscia, L
    RETINAL PIGMENT EPITHELIUM AND MACULAR DISEASES, 1998, 62 : 297 - 299
  • [29] Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis
    Yates, William B.
    Chiong, Fabian
    Zagora, Sophia
    Post, Jeffrey J.
    Wakefield, Denis
    McCluskey, Peter
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2019, 8 (04): : 280 - 284
  • [30] Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?
    Jad, Akesbi
    Celine, Terrada
    Bodaghi, Bahram
    Phuc, LeHoang
    Nathalie, Cassoux
    INTERNATIONAL OPHTHALMOLOGY, 2013, 33 (02) : 189 - 194